Surgery Partners (SGRY) Capital Expenditures (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Capital Expenditures data on file, last reported at $16.0 million in Q1 2026.

• Quarterly Capital Expenditures fell 29.52% year-over-year to $16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.0 million (down 21.82% YoY) and the FY2025 annual result came in at $78.7 million, down 12.94% from the prior year.
• Capital Expenditures rose to $16.0 million in Q1 2026 per SGRY's latest filing, from $12.8 million in the prior quarter.
• The five-year high for Capital Expenditures was $26.9 million in Q2 2024, with the low at $12.8 million in Q4 2025.
• Average Capital Expenditures over 5 years is $20.9 million, with a median of $21.0 million recorded in 2024.
• Year-over-year, Capital Expenditures jumped 65.93% in 2022 and tumbled 42.6% in 2025.
• Surgery Partners' Capital Expenditures stood at $22.7 million in 2022, then fell by 12.78% to $19.8 million in 2023, then grew by 12.63% to $22.3 million in 2024, then plunged by 42.6% to $12.8 million in 2025, then grew by 25.0% to $16.0 million in 2026.
• Business Quant data shows SGRY's Capital Expenditures at $16.0 million in Q1 2026, $12.8 million in Q4 2025, and $19.8 million in Q3 2025.